AdventHealth First in Central Florida to Offer Movement Disorder Patients Access to NeuroSphere Virtual Clinic for Remote Adjustment of Neurostimulation Devices

Deep brain stimulation (DBS), a surgical procedure to help relieve symptoms of movement disorders such as Parkinson’s disease and dystonia, has improved the quality of life for some patients, easing motor symptoms and decreasing medication needs. Electrodes are implanted in a targeted area of the brain to deliver high-frequency electrical stimulation that helps regulate abnormal impulses as well as certain cells and chemicals. The amount of stimulation delivered is controlled by an impulse generator battery (IPG) that is implanted subcutaneously in the patient’s upper chest and connected to the electrodes in the brain. Until recently, patients had to come into a neurology clinic multiple times for adjustment of the device’s programming, especially in the first few months after surgical implantation. In 2021, AdventHealth became the first in Central Florida to offer the NeuroSphere Virtual Clinic, allowing DBS patients to receive their programming adjustments remotely via a telehealth appointment.

Missing media item.
Mitesh Lotia, MD, Movement Disorder Neurologist and Medical Director of the Movement Disorder Program at AdventHealth Neuroscience Institute

Approved by the U.S. Food and Drug Administration (FDA) in March 2021, the NeuroSphere Virtual Clinic provides patients the ability to connect to their physician through a secure patient controller app that includes video chat and integrated remote programming features. The physician can talk with the patient, observe symptoms and prescribe new treatment settings remotely to the patient's neurostimulation device using their clinician programmer app.

“With the NeuroSphere Virtual Clinic, we can provide the same, effective care to our patients in a secure way that is much more convenient for them,” explains Mitesh Lotia, MD, Movement Disorder Neurologist and Medical Director of the Movement Disorder Program at AdventHealth Neuroscience Institute. “Because DBS surgery is only available at larger medical centers, many patients travel several hours to receive treatment. Unfortunately, this can create a burden to accessing the ongoing follow-up care needed to properly regulate their device. Now we have eliminated this obstacle. Patients can receive their programming from the comfort of their home or office.”

AdventHealth offers DBS as a treatment option as appropriate for patients with the following conditions:

  • Parkinson's disease

  • Dystonia

  • Essential tremor

  • Epilepsy

Telehealth visits through the NeuroSphere Virtual Clinic are currently covered by Medicare and private insurances.

To learn more or refer a patient, click here.

Deep Brain Stimulation Treatment - The Ventriloquist

Mark Wade is a well-known ventriloquist who went under Deep Brain Stimulation surgery at AdventHealth Celebration to treat an essential tremor. Learn more about Deep Brain Stimulation and his story by watching the video.

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease

While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...

News

AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)

Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...

News

AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease

Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...

News

New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy

Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...

News

AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease

Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...